Top

Journal of the Association for Research in Otolaryngology

Published in:

01-08-2019 | Gene Therapy in Oncology | Research Article

AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF

Authors: Patricia A. Leake, Stephen J. Rebscher, Chantale Dore‘, Omar Akil

Published in: Journal of the Association for Research in Otolaryngology | Issue 4/2019

Abstract

Outcomes with contemporary cochlear implants (CI) depend partly upon the survival and condition of the cochlear spiral ganglion (SG) neurons. Previous studies indicate that CI stimulation can ameliorate SG neural degeneration after deafness, and brain-derived neurotrophic factor (BDNF) delivered by an osmotic pump can further improve neural survival. However, direct infusion of BDNF elicits undesirable side effects, and osmotic pumps are impractical for clinical application. In this study, we explored the potential for two adeno-associated viral vectors (AAV) to elicit targeted neurotrophic factor expression in the cochlea and promote improved SG and radial nerve fiber survival. Juvenile cats were deafened prior to hearing onset by systemic aminoglycoside injections. Auditory brainstem responses showed profound hearing loss by 16–18 days postnatal. At ~ 4 weeks of age, AAV2-GFP (green fluorescent protein), AAV5-GFP, AAV2-hBDNF, or AAV5-hGDNF (glial-derived neurotrophic factor) was injected through the round window unilaterally. For GFP immunofluorescence, animals were studied ~ 4 weeks post-injection to assess cell types transfected and their distributions. AAV2-GFP immunofluorescence demonstrated strong expression of the GFP reporter gene in residual inner (IHCs), outer hair cells (OHCs), inner pillar cells, and in some SG neurons throughout the cochlea. AAV5-GFP elicited robust transduction of IHCs and some SG neurons, but few OHCs and supporting cells. After AAV-neurotrophic factor injections, animals were studied ~ 3 months post-injection to evaluate neural survival. AAV5-hGDNF elicited a modest neurotrophic effect, with 6 % higher SG density, but had no trophic effect on radial nerve fiber survival, and undesirable ectopic fiber sprouting occurred. AAV2-hBDNF elicited a similar 6 % increase in SG survival, but also resulted in greatly improved radial nerve fiber survival, with no ectopic fiber sprouting. A further study assessed whether AAV2-hBDNF neurotrophic effects would persist over longer post-injection periods. Animals examined 6 months after virus injection showed substantial neurotrophic effects, with 14 % higher SG density and greatly improved radial nerve fiber survival. Our results suggest that AAV-neurotrophin gene therapy can elicit expression of physiological concentrations of neurotrophins in the cochlea, supporting improved SG neuronal and radial nerve fiber survival while avoiding undesirable side effects. These studies also demonstrate the potential for application of cochlear gene therapy in a large mammalian cochlea comparable to the human cochlea and in an animal model of congenital/early acquired deafness.

Agterberg MJH, Versnel H, van Dijk LM, de Groot JC, Klis SF (2009) Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs. J Assoc Res Otolaryngol 10:355–367. https://doi.org/10.1007/s10162-009-0170-2 CrossRefPubMedPubMedCentral

Agterberg MJ, Versnel H, de Groot JC, Smoorenburg GF, Albers FW, Klis SF (2008) Morphological changes in spiral ganglion cells after intracochlear application of brain-derived neurotrophic factor in deafened guinea pigs. Hear Res 244:25–34. https://doi.org/10.1016/j.heares.2008.07.004 CrossRefPubMed

Akil O, Blits B, Lustig L, Leake P (2019) Virally-mediated over-expression of GDNF elicits age- and dose-dependent neuronal toxicity and hearing loss. Hum Gene Ther 30(1):88–105CrossRefPubMedPubMedCentral

Atkinson PJ, Wise AK, Flynn BO, Nayaqam BA, Richardson RT (2014) Hair cell regeneration after ATOH1 gene therapy in the cochlea of profoundly deaf adult guinea pigs. PLoS One 18, 9(7). https://doi.org/10.1371/journal.pone.0102077

Ballana E, Wang J, Venail F, Estivill X, Puel J-L, Arbones ML et al (2008) Efficient and specific transduction of cochlear supporting cells by adenoassociated virus serotype 5. Neurosci Lett 442(2):134–139. https://doi.org/10.1016/j.neulet.2008.06.060

Bennett J, Ashtari M, Wellman J, Marshall KA, Cyckowski LL, Chung DD, McCaque S, Pierce EA, Chen Y, Bennicelli JL, Zhu X, Ying GS, Sun J, Wright JF, Auricchio A, Simonelli F, Shindler KS, Minqozzi F, high KA, Maquire AM (2012) AAV2 gene therapy readministration in three adults with congenital blindness. Sci Transl Med 4(120):120ra15. https://doi.org/10.1126/scitranslmed.3002865 CrossRefPubMedPubMedCentral

Budenz CL, Wong HT, Swiderski DL, Shibata SB, Pfingst BE, Raphael Y (2015) Differential effects of AAV.BDNF and AAV.Ntf3 in the deafened adult guinea pig ear. Sci Rep 5:8619. https://doi.org/10.1038/srep08619 CrossRefPubMedPubMedCentral

Chikar JA, Colesa DJ, Swiderski DL, Di Polo A, Raphael Y, Pfingst BE (2008) Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons. Hear Res 245:24–34. https://doi.org/10.1016/j.heares.2008.08.005 CrossRefPubMedPubMedCentral

Drennan WR, Rubinstein JT (2008) Music perception in cochlear implant users and its relationship with psychophysical capabilities. J Rehabil Res Dev 45:779–789CrossRefPubMedPubMedCentral

Endo T, Nakagawa T, Kita T, Iguchi F, Kim TS, Tamura T, Iwai K, Tabata Y, Ito J (2005) Novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope 115:2016–2020. https://doi.org/10.1097/01.mlg.0000183020.32435.59 CrossRefPubMed

Fariñas I, Jones KR, Tessarollo L et al (2001) Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression. J Neurosci 21:6170–6180CrossRefPubMedPubMedCentral

Fernandez KA, Jeffers PW, Lall K, Liberman MC, Kujawa SG (2015) Aging after noise exposure: acceleration of cochlear synaptopathy in “recovered” ears. J Neurosci 35(19):7509–7520. https://doi.org/10.1523/JNEUROSCI.5138-14.2015 CrossRefPubMedPubMedCentral

Firszt JB, Holden LK, Skinner MW, Tobey EA, Petersen A, Gaggl W, Runge-Samuelson CL, Wackym PA (2004) Recognition of speech presented at soft to loud levels by adult cochlear implant recipients of three cochlear implant systems. Ear Hear 25:375–387CrossRefPubMed

Fritzsch B, Pirvola U, Ylikoski J (1999) Making and breaking the innervation of the ear: neurotrophic support during ear development and its clinical implications. Cell Tissue Res 295:369–382CrossRefPubMed

Gao WQ, Zheng JL, Karihaloo M (1995) Neurotrophin-4/5 (NT-4/5) and brain-derived neurotrophic factor (BDNF) act at later stages of cerebellar granule cell differentiation. J Neurosci 15:2656–2667CrossRefPubMedPubMedCentral

Geers AE (2004) Speech, language, and reading skills after early cochlear implantation. Arch Otolaryngol Head Neck Surg 130:634–638. https://doi.org/10.1001/archotol.130.5.634 CrossRefPubMed

Glueckert R, Bitsche M, Miller JM, Zhu Y, Prieskorn DM, Altschuler RA, Schrott-Fischer A (2008) Deafferentation-associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain-derived neurotrophic factor and acidic fibroblast growth factor. J Comp Neurol 507:1602–1621. https://doi.org/10.1002/cne.21619 CrossRefPubMed

Grieger JC, Samulski RJ (2012) Adeno-associated virus vectorology, manufacturing, and clinical applications. Methods Enzymol 507:229–254. https://doi.org/10.1016/B978-0-12-386509-0.00012-0 CrossRefPubMed

Gyorgy B, Sage C, Indzhykulian AA, Scheffer DI, Brisson AR, Tan S, Wu X, Volak A, Mu D, Tamvakologos PI, Li Y, Fitzpatrik Z, Ericsson M, Breakefield XO, Corey DP, Maguire CA (2017) Rescue of hearing by gene delivery to inner-ear hair cells using exosomeo-associated AAV. Mol Ther 25(2):379–391. https://doi.org/10.1016/j.ymthe.2016

Hansen MR, Zha XM, Bok J, Green SH (2001) Multiple distinct signal pathways, including an autocrine neurotrophic mechanism, contribute to the survival-promoting effect of depolarization on spiral ganglion neurons in vitro. J Neurosci 21:2256–2267CrossRefPubMedPubMedCentral

Hegarty JL, Kay AR, Green SH (1997) Trophic support of cultured spiral ganglion neurons by depolarization exceeds and is additive with that by neurotrophins or cAMP and requires elevation of [Ca2+]i within a set range. J Neurosci 17:1959–1970CrossRefPubMedPubMedCentral

Hendricks JL, Chikar JA, Crumling MA, Raphael Y, Martin DC (2008) Localized cell and drug delivery for auditory prostheses. Hear Res 242:117–131. https://doi.org/10.1016/j.heares.2008.06.003 CrossRefPubMedPubMedCentral

Hochmair I, Nopp P, Jolly C, Schmidt M, Schosser H, Garnham C, Anderson I (2006) MED-EL cochlear implants: state of the art and a glimpse into the future. Trends Amplif 10:201–219. https://doi.org/10.1177/1084713806296720 CrossRefPubMedPubMedCentral

Holden LK, Finley CC, Firszt JB, Holden TA, Brenner C, Potts LG, Gotter BD, Vanderhoof SS, Mispagel K, Heydebrand G, Skinner MW (2013) Factors affecting open-set word recognition in adults with cochlear implants. Ear Hear. https://doi.org/10.1097/AUD.0b013e3182741aa7

Ibanez CF, Andressoo JO (2017) Biology of GDNF and its receptors—relevance for disorders of the central nervous system. Neurobiol Dis 97:80–89. https://doi.org/10.1016/j.nbd.2016.01.021 CrossRefPubMed

Jiam NT, Deroche ML, Jiradejvong P, Limb CJ (2019) A randomized controlled crossover study of the impact of online music training on pitch and timbre perception in cochlear implant users. JARO. https://doi.org/10.1007/s10162-018-00704-0

Kanzaki S, Stöver T, Kawamoto K, Prieskorn DM, Altschuler RA, Miller JM, Raphael Y (2002) Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J Comp Neurol 454:350–360. https://doi.org/10.1002/cne.10480 CrossRefPubMed

Khalin I, Alyautdin R, Kocherga G, Abu Bakar M (2015) Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness. Int J Nanomedicine 10:3245–3267. https://doi.org/10.2147/IJN.S77480.eCollection2015

Konishi M, Kawamoto K, Izumikawa M, Kuriyama H, Yamashita T (2008) Gene transfer into guinea pig cochlea using adeno-associated virus vectors. J Gene Med 10(6):610–618. https://doi.org/10.1002/jgm.1189

Korsching S (1993) The neurotrophic factor concept: a reexamination. J Neurosci 13:2739–2748CrossRefPubMedPubMedCentral

Kujawa SG, Liberman MC (2015) Synaptopathy in the noise-exposed and aging cochlea: primary neural degeneration in acquired sensorineural hearing loss. Hear Res 330(Pt B):191–199. https://doi.org/10.1016/j.heares.2015.02.009 CrossRefPubMedPubMedCentral

Leake PA, Hradek GT, Hetherington AM, Stakhovskaya O (2011) Brain-derived neurotrophic factor promotes cochlear spiral ganglion cell survival and function in deafened, developing cats. J Comp Neurol 519:1526–1545. https://doi.org/10.1002/cne.22582 CrossRefPubMedPubMedCentral

Leake PA, Hradek GT, Snyder RL (1999) Chronic electrical stimulation by a cochlear implant promotes survival of spiral ganglion neurons after neonatal deafness. J Comp Neurol 412:543–562CrossRefPubMed

Leake PA, Hradek GT, Vollmer M, Rebscher SJ (2007) Neurotrophic effects of GM1 ganglioside and electrical stimulation on cochlear spiral ganglion neurons in cats deafened as neonates. J Comp Neurol 501:837–853. https://doi.org/10.1002/cne.21275 CrossRefPubMedPubMedCentral

Leake PA, Stakhovskaya O, Hradek GT, Hetherington AM (2008) Factors influencing neurotrophic effects of electrical stimulation in the deafened developing auditory system. Hear Res 242:86–99. https://doi.org/10.1016/j.heares.2008.06.002 CrossRefPubMedPubMedCentral

Leake PA, Stakhovskaya O, Hetherington A, Rebscher SJ, Bonham B (2013) Effects of brain-derived neurotrophic factor (BDNF) and electrical stimulation on survival and function of cochlear spiral ganglion neurons in deafened, developing cats. J Assoc Res Otolaryngol Apr 14(2):187–211. https://doi.org/10.1007/s10162-013-0372-5 CrossRefPubMedPubMedCentral

Liberman LD, Suzuki J, Liberman MC (2015) Dynamics of cochlear synaptopathy after acoustic overexposure. J Assoc Res Otolaryngol 16(2):205–219. https://doi.org/10.1007/s10162-015-0510-3 CrossRefPubMedPubMedCentral

Lustig LR, Akil O (2012) Cochlear gene therapy. Curr Opin Neurol 25(1):57–60. https://doi.org/10.1097/WCO.0b013e32834f038c

Mackary CA, Shin J, Kujawa SG, Liberman MC, Merchant SN (2011) Age-related primary cochlear neuronal degeneration in human temporal bones. J Assoc Res Otolaryngol 12(6):711–717CrossRef

Maruyama J, Miller JM, Ulfendahl M (2008) Glial cell line-derived neurotrophic factor and antioxidants preserve the electrical responsiveness of the spiral ganglion neurons after experimentally induced deafness. Neurobiol Dis 29:14–21. https://doi.org/10.1016/j.nbd.2007.07.026 CrossRefPubMed

Miller JM, Le Prell CG, Prieskorn DM, Wys NL, Altschuler RA (2007) Delayed neurotrophin treatment following deafness rescues spiral ganglion cells from death and promotes regrowth of auditory nerve peripheral processes: effects of brain-derived neurotrophic factor and fibroblast growth factor. J Neurosci Res 85:1959–1969. https://doi.org/10.1002/jnr.21320 CrossRefPubMed

Mouton PR (2002) Principles and practices of unbiased stereology: an introduction for bioscientists. Johns Hopkins University Press, Baltimore ISBN 0-8018-6797-5

Nakaizumi T, Kawamoto K, Minoda R, Raphael Y (2004) Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol Neurootol 9:135–143. https://doi.org/10.1159/000077264 CrossRefPubMed

Nicholas JG, Geers AE (2007) Will they catch up? The role of age at cochlear implantation in the spoken language development of children with severe to profound hearing loss. J Speech Lang Hear Res 50:1048–1062. https://doi.org/10.1044/1092-4388(2007/073) CrossRefPubMed

Ortmann M, Zwitserlood P, Knief A, Baare J, Crinkheetker S, Am Zehnhoff-Dinnesen A, Dobel C (2017) When hearing is tricky: speech processing strategies in prelingually deafened children and adolescents with cochlear implants having good and poor speech performance. PLoS One 12(1). https://doi.org/10.1371/journal.pone.0168655

Patricio MI, Barnard AR, Xue K, MacLaren RE (2018) Choroideremia: molecular mechanisms and development of AAV gene therapy. Expert Opin Biol Ther 18(7):807–820. https://doi.org/10.1080/14712598.2018.1484448

Pettingill LN, Minter RL, Shepherd RK (2008) Schwann cells genetically modified to express neurotrophins promote spiral ganglion neuron survival in vitro. Neuroscience 152:821–828. https://doi.org/10.1016/j.neuroscience.2007.11.057 CrossRefPubMed

Pfingst BE, Colesa DJ, Swiderski DL, Hughes AP, Strahl SB, Sinan M, Raphael Y (2017) Neurotrophin gene therapy in deafened ears with cochlear implants: long-term effects on nerve survival and functional measures. JARO 18:731–750. https://doi.org/10.1007/s10162-017-0633-9 CrossRefPubMedPubMedCentral

Pierce EA, Bennett J (2015) The status of RPE65 gene therapy trials: Safety and efficacy. Cold Spring Har Perspect Med 5(9):a017285. https://doi.org/10.1101/cshperspect.a017285

Ramekers D, Versnel H, Grolman W, Klis SF (2012) Neurotrophins and their role in the cochlea. Hear Res. https://doi.org/10.1016/j.heares.2012.03.002

Ramekers D, Versnel H, Strahl SB, Klis SFL, Grolman W (2015) Temporary neurotrophin treatment prevents deafness-induced auditory nerve degeneration and preserves function. J Neurosci 35(36):12331–12345. https://doi.org/10.1523/JNEUROSCI.0096-15.2015 CrossRefPubMedPubMedCentral

Rebscher SJ, Hetherington AM, Snyder RL, Leake PA, Bonham BH (2007) Design and fabrication of multichannel cochlear implants for animal research. J Neurosci Methods 166:1–12. https://doi.org/10.1016/j.jneumeth.2007.05.013 CrossRefPubMedPubMedCentral

Rejali D, Lee VA, Abrashkin KA, Humayun N, Swiderski DL, Raphael Y (2007) Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons. Hear Res 228:180–187. https://doi.org/10.1016/j.heares.2007.02.010 CrossRefPubMedPubMedCentral

Richardson RT, Wise AK, Andrew JK, O’Leary SJ (2008) Novel drug delivery systems for inner ear protection and regeneration after hearing loss. Expert Opin Drug Deliv 5:1059–1076. https://doi.org/10.1517/17425247.5.10.1059 CrossRefPubMed

Rubel EW, Fritzsch B (2002) Auditory system development: primary auditory neurons and their targets. Annu Rev Neurosci 25:51–101. https://doi.org/10.1146/annurev.neuro.25.112701.142849 CrossRefPubMed

Shepherd RK, Coco A, Epp SB (2008) Neurotrophins and electrical stimulation for protection and repair of spiral ganglion neurons following sensorineural hearing loss. Hear Res 242:100–109. https://doi.org/10.1016/j.heares.2007.12.005 CrossRefPubMed

Shepherd RK, Coco A, Epp SB, Crook JM (2005) Chronic depolarization enhances the trophic effects of brain-derived neurotrophic factor in rescuing auditory neurons following a sensorineural hearing loss. J Comp Neurol 486:145–158. https://doi.org/10.1002/cne.20564 CrossRefPubMedPubMedCentral

Shibata SB, Cortez SR, Beyer LA, Wiler JA, Di Polo A, Pfingst BE, Raphael Y (2010) Transgenic BDNF induces nerve fiber regrowth into the auditory epithelium in deaf cochleae. Exp Neurol 223:464–472. https://doi.org/10.1016/j.expneurol.2010.01.011 CrossRefPubMedPubMedCentral

Simonelli F, Maguire AM, Testa F, Pierce EA, Mingozzi F, Bennicelli JL, Rossi S, Marshall K, Banfi S, Surace EM, Sun J, Redmond TM, Zhu X, Shindler KS, Ying GS, Ziviello C, Acerra C, Wright JF, McDonnell JW, High KA, Bennett J, Auricchio A (2010) Gene therapy for Leber’s congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther 18(3):643–650. https://doi.org/10.1038/mt.2009.277 CrossRefPubMed

Staecker H, Jolly C, Garnham C (2010) Cochlear implantation: an opportunity for drug development. Drug Discov Today 15:314–321. https://doi.org/10.1016/j.drudis.2010.02.005 CrossRefPubMed

Suzuki J, Hashimoto K, Xiao R, Vandenberghe LH, Liberman MC (2017) Cochlear gene therapy with ancestral AAV in adult mice: complete transduction of inner hair cells without cochlear dysfunction. Sci Rep 7:45524. https://doi.org/10.1038/srep45524 CrossRefPubMedPubMedCentral

Svirsky MA, Robbins AM, Kirk KI, Pisoni DB, Miyamoto RT (2000) Language development in profoundly deaf children with cochlear implants. Psychol Sci 11:153–158CrossRefPubMed

Tao Y, Huang M, Shu Y, Ruprecht A, Wang H, Tang Y, Vandenberghe LH, Wang Q, Gao G, Kong WJ, Chen ZY (2018) Delivery of adeno-associated virus vectors in adult mammalian inner-ear cell subtypes without auditory dysfunction. Hum Gene Ther 29(4):492–506. https://doi.org/10.1089/hum.2017.120

Tessarollo L, Coppola V, Fritzsch B (2004) NT-3 replacement with brain-derived neurotrophic factor redirects vestibular nerve fibers to the cochlea. J Neurosci 24:2575–2584. https://doi.org/10.1523/JNEUROSCI.5514-03.2004 CrossRefPubMedPubMedCentral

Tobey EA, Thal D, Niparko JK, Eisenberg LS, Quittner AL, Wang N-Y, CDaCI Team (2013) Influence of implantation age on school-age language performance in pediatric cochlear implant users. Int J Audiol 52(4):219–229. https://doi.org/10.3109/14992027.2012.759666 CrossRefPubMedPubMedCentral

Viana LM, O'Malley JT, Burgess BJ, Jones DD, Oliveira CA, Santos F, Merchant SN, Liberman LD, Liberman MC (2015) Cochlear neuropathy in human presbycusis: confocal analysis of hidden hearing loss in post-mortem tissue. Hear Res 327:78–88. https://doi.org/10.1016/j.heares.2015.04.014

Warnecke A, Wissel K, Hoffmann A, Hofmann N, Berkingali N, Gro G, Lenarz T, Stover T (2007) The biological effects of cell-delivered brain-derived neurotrophic factor on cultured spiral ganglion cells. Neuroreport 18:1683–1686. https://doi.org/10.1097/WNR.0b013e3282f0b5d7 CrossRefPubMed

Wise AK, Fallon JB, Neil AJ, Pettingill LN, Geaney MS, Skinner SJ, Shepherd RK (2011) Combining cell-based therapies and neural prostheses to promote neural survival. Neurotherapeutics 8:774–787. https://doi.org/10.1007/s13311-011-0070-0 CrossRefPubMedPubMedCentral

Wise AK, Hume CR, Flynn BO, Jeelall YS, Suhr CL, Sgro BE, O’Leary SJ, Shepherd RK, Richardson RT (2010) Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea. Mol Ther 18:1111–1122. https://doi.org/10.1038/mt.2010.28 CrossRefPubMedPubMedCentral

Wise AK, Richardson R, Hardman J, Clark G, O’Leary S (2005) Resprouting and survival of Guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3. J Comp Neurol 487:147–165. https://doi.org/10.1002/cne.20563 CrossRefPubMed

Won JH, Jones GL, Drennan WR, Jameyson EM, Rubinstein JT (2011) Evidence of across-channel processing for spectral-ripple discrimination in cochlear implant listeners. J Acoust Soc AM 130(4):2088–2097. https://doi.org/10.1121/1.3624820

Xia L, Yin S, Wang J (2012) Inner ear gene transfection in neonatal mice using adeno-associated viral vector: a comparison of two approaches. Plos One 7(8):e43218. https://doi.org/10.1371/journal.pone.0043218

Yagi M, Kanzaki S, Kawamoto K, Shin B, Shah PP, Magal E, Sheng J, Raphael Y (2000) Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J Assoc Res Otolaryngol 1:315–325PubMedPubMedCentral

Yang T, Kersigo J, Jahan I, Pan N, Fritzsch B (2011) The molecular basis of making spiral ganglion neurons and connecting them to hair cells of the organ of Corti. Hear Res 278:21–33. https://doi.org/10.1016/j.heares.2011.03.002

Ylikoski J, Pirvola U, Virkkala J, Suvanto P, Liang XQ, Magal E, Altschuler R, Miller JM, Saarma M (1998) Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma. Hear Res 124:17–26CrossRefPubMed

Zeng F-G, Rebscher S, Harrison W, Sun X, Fen H (2008) Cochlear implants: system design, integration, and evaluation. IEEE Rev Biomed Eng 1:115–142. https://doi.org/10.1109/RBME.2008.2008250 CrossRefPubMedPubMedCentral

Zha XM, Bishop JF, Hansen MR, Victoria L, Abbas PJ, Mouradian MM, Green SH (2001) BDNF synthesis in spiral ganglion neurons is constitutive and CREB-dependent. Hear Res 156:53–68CrossRefPubMed

Zhao Y, Li Y, Zheng Z, Li J, Nie X, Jin X, Zheng J, Zhang J, Chen M, Hao J, Yang Y, Liu W, Liu H, Ni X (2019) Health-Related quality of life in Mandarin-speaking children with cochlear implants. Ear Hear 40(3):605–614. https://doi.org/10.1097/AUD.0000000000000633

Zilberstein Y, Liberman MC, Corfas G (2012) Inner hair cells are not required for survival of spiral ganglion neurons in the adult cochlea. J Neurosci 32(2):405–410. https://doi.org/10.1523/JNEUROSCI.4678-11.2012 CrossRefPubMedPubMedCentral

Title: AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF
Authors: Patricia A. Leake
Stephen J. Rebscher
Chantale Dore‘
Omar Akil
Publication date: 01-08-2019
Publisher: Springer US
Keywords: Gene Therapy in Oncology
Cochlear Implant
Published in: Journal of the Association for Research in Otolaryngology / Issue 4/2019
Print ISSN: 1525-3961
Electronic ISSN: 1438-7573
DOI: https://doi.org/10.1007/s10162-019-00723-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2019

Neural Encoding of Amplitude Modulations in the Human Efferent System

Virtual Rhesus Labyrinth Model Predicts Responses to Electrical Stimulation Delivered by a Vestibular Prosthesis

Evaluating Psychophysical Polarity Sensitivity as an Indirect Estimate of Neural Status in Cochlear Implant Listeners

The fMRI Data of Thompson et al. (2006) Do Not Constrain How the Human Midbrain Represents Interaural Time Delay

A Site-Selection Strategy Based on Polarity Sensitivity for Cochlear Implants: Effects on Spectro-Temporal Resolution and Speech Perception

Exploring the Role of Medial Olivocochlear Efferents on the Detection of Amplitude Modulation for Tones Presented in Noise